FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/13/2024
Back to search
Official data from USPTO
SMARTLNP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
02/13/2024
Trademark type
Combined
Nice classes
1
Filing date
10/06/2021
Registration date
10/17/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/17/2023
Last transaction
10/17/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
KR
Examiner
FALK,JONATHAN ROBERT
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ST PHARM CO., LTD.
Representatives
N. Christopher Norton ArentFox Schiff LLP
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical additives for industrial purposes; reagents for scientific purposes; reagents for medical research; chemicals for use in biotechnological manufacturing processes; chemicals for use in biotechnological product development; biological preparations for use in biotechnology science other than medical use; chemical preparations for use in the manufacture of pharmaceuticals; chemicals for the manufacture of vaccines; chemicals for the manufacture of nucleic acids; chemicals for the manufacture of mRNA drugs; chemicals for use in the manufacture of preparations for mRNA therapeutics; chemicals for the manufacture of mRNA vaccines; excipients for drug delivery for use in the manufacture of pharmaceutical preparations; lipid nanoparticles for drug delivery being chemical preparations for use in the manufacture of pharmaceuticals; excipients for mRNA drug delivery for use in the manufacture of pharmaceutical preparations; lipid nanoparticles for mRNA drug delivery being chemical preparations for use in the manufacture of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
28 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/19/2024
FIMP
FINAL DISPOSITION PROCESSED
01/19/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/17/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/17/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/17/2023
GPNX
NOTIFICATION PROCESSED BY IB
08/14/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/01/2023
PUBO
PUBLISHED FOR OPPOSITION
08/01/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/26/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/26/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/12/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/26/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/01/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/12/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/09/2023
RFNT
REFUSAL PROCESSED BY IB
08/02/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/08/2022
RFRR
REFUSAL PROCESSED BY MPU
07/08/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/07/2022
CNRT
NON-FINAL ACTION WRITTEN
07/06/2022
DOCK
ASSIGNED TO EXAMINER
06/21/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/19/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/15/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/11/2021
Continuous trademark protection
Get notified about every new filing that threatens SMARTLNP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.